ESH-SIOG international conference on haematological malignancies in the elderly

Expert Review of Hematology

Volumn 3, Issue 6, 2010, Pages 675-677

  Balducci, Lodovico ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BORTEZOMIB; COBALAMIN; COPPER; CYCLOPHOSPHAMIDE; DOXORUBICIN; ERYTHROPOIETIN; FERROPORTIN; FOLIC ACID; HEPCIDIN; IRON; LENALIDOMIDE; MELPHALAN; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; THALIDOMIDE; VINCRISTINE;

AGING; ANEMIA; BONE MARROW TOXICITY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER INCIDENCE; CANCER PATIENT; CARDIOMYOPATHY; CHRONIC KIDNEY FAILURE; CLINICAL DECISION MAKING; CLINICAL PRACTICE; CLINICAL TRIAL; CONFERENCE PAPER; COPPER DEFICIENCY; CYANOCOBALAMIN DEFICIENCY; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; ELDERLY CARE; ERYTHROPOIETIN DEFICIENCY; HEMATOLOGIC MALIGNANCY; HUMAN; IRON DEFICIENCY; LEUKEMIA; LIFE EXPECTANCY; LYMPHOMA; MORTALITY; MUCOSA INFLAMMATION; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; MYELOMA; NEUROTOXICITY; NEUTROPENIA; NUTRITIONAL DEFICIENCY; PERIPHERAL NEUROPATHY; PREVALENCE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS;

AGED; AGING; ANTINEOPLASTIC AGENTS; HEMATOLOGIC NEOPLASMS; HUMANS;

EID: 78649504724     PISSN: 17474086     EISSN: None     Source Type: Journal    
DOI: 10.1586/ehm.10.72     Document Type: Conference Paper

References (11)

1. Brunello A, Sandri R, Extermann M. Multidimensional geriatric evaluation of the older cancer patient as a clinical and a research tool. Cancer Treat. Rev. 35(6), 487-492 (2009).
2. Inouye SK, Studenski S, Tinetti ME. Geriatric syndromes: Clinical, research, and policy implications of a core geriatric concept. J. Am. Geriatr. Soc. 55(5), 780-791 (2007).
3. Carey EC, Covinsky KE, Lui LY et al. Prediction of mortality in communityliving frail elderly people with long-term care needs. J. Am. Geriatr. Soc. 56(1), 68-75 (2008).
4. Extermann M, Boler I, Reich R et al. The Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score: Design and validation. Presented at: 2010 ASCO Annual Meeting. Chicago, IL, USA, 4-8 June 2010 (Abstract 9000).
5. Hurria A, Togawa K, Mohile SG et al. Predicting chemotherapy toxicity in older adults with cancer: A prospective 500 patient multicenter study. Presented at: 2010 ASCO Annual Meeting. Chicago, IL, USA, 4-8 June 2010 (Abstract 9001).
6. Gruenewald TL, Seeman TE, Karlamangla AS et al. Allostatic load and frailty in older individuals. J. Am. Geriatr. Soc. 57(9), 1525-1531 (2009).
7. Freund A, Orjalo AV, Desprez PY et al. Inflammatory network during senescence: Causes and consequences. Trends Mol. Med. 16(5), 238-246 (2010).
8. Risques RA, Arbeev KG, Yashin AI et al. Leukocyte telomere length is associated with disability in the older USA population. J. Am. Ger. Soc. 58, 1289-1298 (2010).
9. Ferrucci L, Balducci L. Anemia of aging: Role of chronic inflammation and cancer. Semin. Hematol. 45, 242-249 (2008).
10. Komrokji RS, List AF. Lenalidomide in the treatment of myelodysplastic syndromes: Current status and future directions. Hematol. Oncol. Clin. North Am. 24(2), 377-388 (2010).
11. Carreca I, Balducci L. Cancer chemotherapy in the older cancer patient. Urol. Oncol. 27(6), 633-642 (2009).